Citius Oncology (CTOR) Other Operating Expenses (2023 - 2026)

Citius Oncology's Other Operating Expenses history runs 4 years deep, the most recent figure standing at $4.7 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 207.71% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $12.1 million (up 184.39% YoY), while the FY2025 annual figure was $6.1 million, up 8.25% from the prior year.
• Other Operating Expenses was $4.7 million for Q1 2026 at Citius Oncology, up from $4.0 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $4.7 million in Q1 2026 to a low of $1.2 million in Q4 2024.
• Historically, Other Operating Expenses has averaged $2.1 million across 4 years, with a median of $1.5 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Operating Expenses retreated 17.01% in 2024, then jumped 224.98% in 2025.
• A 4-year view of Other Operating Expenses shows it stood at $1.5 million in 2023, then decreased by 17.01% to $1.2 million in 2024, then surged by 224.98% to $4.0 million in 2025, then climbed by 16.06% to $4.7 million in 2026.
• The last three Other Operating Expenses figures came in at $4.7 million (Q1 2026), $4.0 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.